1,06 risk_ratioThe intervention improved retention in care with a risk ratio of 1.06 (95% CI: 1.02–1.1).
KenyaVIH/sidaobservé 48 weekspublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 6 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
2 235 evidences · page 74 / 90
1,06 risk_ratioThe intervention improved retention in care with a risk ratio of 1.06 (95% CI: 1.02–1.1).
KenyaVIH/sidaobservé 48 weekspublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 6 observations
43,7 %Among 11,239 HIV-positive persons who named ≥1 contact in the SEARCH Study in rural Kenya and Uganda between 2013 and 2014, 43.7% had not initiated treatment.
KenyaVIH/sidaobservé 2013 and 2014publié 2021Epidemiology (Cambridge, Mass.)PubMeddocument de 3 observations
12,9 %12.9% (1104) of HIV-positive adolescents were pregnant at study inclusion.
KenyaVIH/sidapublié 2020Reproductive healthPubMeddocument de 8 observations
96,9 %The specificity of provider-delivered HIVST at the pharmacy was 96.9% when interpreted by providers.
KenyaVIH/sidaobservé between March and June 2022publié 2023Journal of the International AIDS SocietyPubMeddocument de 9 observations
6,8 %During the pandemic, 6.8% of adolescents with recent history of being lost to program (LTP) reported increased difficulties refilling antiretroviral therapy, compared to 0.7% of those retained in care.
KenyaVIH/sidaobservé July 2020-January 2021publié 2021PloS onePubMeddocument de 6 observations
0,68 kgPeople living with HIV on tenofovir/lamivudine/dolutegravir (TLD) gained an average of 0.68 kg more than those on other antiretroviral regimens after adjusting for duration on ART, sex, age, study site and CD4 nadir.
KenyaVIH/sidapublié 2022Journal of the International AIDS SocietyPubMeddocument de 4 observations
18 %Site-specific viral rebound rates were 18.0% in Meru.
KenyaVIH/sidapublié 2020International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 9 observations
7,1 indexesAmong 783 indexes, the number needed to interview (NNTI) to identify one partner unaware of their HIV status was 7.1.
KenyaVIH/sidapublié 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 8 observations
12 daysTime to completion of at least 3 enhanced adherence counseling sessions was reduced by a median of 12 days, from 59.0 days to 47.5 days before versus after implementation of the standardized enhanced adherence counseling package.
KenyaVIH/sidapublié 2022MedicinePubMeddocument de 12 observations
63 %Six months following treatment initiation, 63% of control participants were virally suppressed.
KenyaVIH/sidapublié 2023BMC public healtheurope_pmcdocument de 5 observationsDOI 10.1186/s12889-023-15638-3
Immunoglobulin G3 (IgG3) concentrations negatively correlated with CAP045 HIV-1 mobility.
KenyaVIH/sidapublié 2025Frontiers in immunologyPubMeddocument de 4 observations
35,9 %The prevalence of pretreatment drug resistance (PDR) was 35.9% among recently diagnosed and treatment-naive female sex workers in Nairobi, Kenya.
KenyaVIH/sidaobservé 2020-2021publié 2023MedicinePubMeddocument de 3 observations
7,5 %The contribution of index testing services to the total number of HIV-positive individuals identified increased from 7.5% in the first year to 28.6% in the second year of implementation in Nairobi County (p < 0.001).
KenyaVIH/sidapublié 2023Tropical medicine & international health : TM & IHPubMeddocument de 8 observations
0,62 p_valueThe p-value for change in monthly PrEP uptake over six months post-training was 0.62.
KenyaVIH/sidapublié 2022PLOS global public healtheurope_pmcdocument de 6 observations
41 %The overall viral rebound rate was 41%.
KenyaVIH/sidapublié 2020International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 9 observations
2,4 yearsA total of 174 HIV-positive children with a median age of 2.4 years were enrolled in the study.
KenyaVIH/sidaobservé 2017-2018publié 2020PloS onePubMeddocument de 8 observations
3,2 relative_risk_ratioHaving more than 5 resistance mutations at timepoint 1 was associated with higher loss to follow-up, with a relative risk ratio of 3.2 (95% confidence interval: 1.1 to 9.2).
KenyaVIH/sidapublié 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 13 observations
5 %Obstructive impairments were observed in 5% of adolescents with HIV in Nairobi, Kenya.
KenyaVIH/sidapublié 2025ChestPubMeddocument de 9 observations
People living with HIV had higher odds of anemia compared to those without HIV.
Kenyaanémie · VIH/sidapublié 2023International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 8 observations
52 %Within the year preceding the survey, 52% of women living with HIV reported experiencing discrimination due to their HIV status.
KenyaVIH/sidaobservé within the year preceding the surveypublié 2021BMC women's healthPubMeddocument de 7 observations
8 %Among 607 survey responders (86% of 704 seroconverters), 8% of men reported a suspected infection source ≥10 years older than themselves.
KenyaVIH/sidapublié 2021PloS onePubMeddocument de 16 observations
TNF-α and TGF-β were significantly reduced in HIV-1 HAART adherent patients at 12 months compared to those at 6 months.
KenyaVIH/sidapublié 2021African health sciencesPubMeddocument de 5 observations
The multi-drug resistance mutation Q151M was observed.
KenyaVIH/sidapublié 2009AIDS research and therapyeurope_pmcdocument de 8 observations
90 %Among pregnant (≥27 weeks) and postpartum (≤6 months) women in HIV care in Kisumu, Kenya, 90% of viral load results returned by Mentor Mothers were suppressed.
KenyaVIH/sidaobservé June-December 2023publié 2026AIDS and behaviorPubMeddocument de 4 observations
89 %Most patients with persistent low-level viremia (89%) achieved nondetectable viral load after continued antiretroviral therapy monitoring for at least 12 months.
KenyaVIH/sidapublié 2023BioMed research internationalPubMeddocument de 6 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.